AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16447644 — intervention group
Group type: COMPARATOR
Intervention: Control (DLS)
Number of subjects: 43
Study 12540331 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily hypertonic saline nasal irrigation for 6 months
Number of subjects: 76
Study 12540331 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 76
Study 9824407 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin spray solution delivering 0.15 mg of capsaicin per nostril once every second or third day for a total of seven treatments.
Number of subjects: 0
Study 9824407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8109551 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of benazepril
Number of subjects: 18
Study 8109551 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of benazepril
Number of subjects: 18
Study 8109551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2681393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole 200 mg
Number of subjects: 568
Study 2681393 — intervention group
Group type: COMPARATOR
Intervention: Pyrantel 10 mg/kg
Number of subjects: 568
Study 772581 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (Ritalin) for 60 days
Number of subjects: 40
Study 772581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31080007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (30mL of 0.375% ropivacaine)
Number of subjects: 63
Study 31080007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine with Clonidine (30mL of 0.375% ropivacaine with clonidine 1μg.kg‐1)
Number of subjects: 63
Study 31080007 — intervention group
Group type: COMPARATOR
Intervention: Control (30mL saline)
Number of subjects: 63
Study 29084663 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil
Number of subjects: 0
Study 29084663 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 0
Study 29084663 — intervention group
Group type: COMPARATOR
Intervention: Flurbiprofen
Number of subjects: 0
Study 25880822 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact for 60 minutes, twice a day for 7 days
Number of subjects: 102
Study 25880822 — intervention group
Group type: COMPARATOR
Intervention: Routine care without skin-to-skin contact
Number of subjects: 102
Study 23994975 — intervention group
Group type: EXPERIMENTAL
Intervention: Left cardiac catheterization
Number of subjects: 167
Study 23994975 — intervention group
Group type: COMPARATOR
Intervention: Multidetector computed tomography (MDCT)
Number of subjects: 167
Study 21430518 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (6 ml/kg)
Number of subjects: 149
Study 21430518 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 ml/kg tidal volume)
Number of subjects: 149
Study 19132780 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific neck stabilization exercises with general neck advice and exercise program
Number of subjects: 74
Study 19132780 — intervention group
Group type: COMPARATOR
Intervention: General neck advice and exercise program alone
Number of subjects: 74
Study 17499444 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counseling (exercise group)
Number of subjects: 299
Study 17499444 — intervention group
Group type: COMPARATOR
Intervention: Health education advice (control group)
Number of subjects: 299
Study 15501201 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g/d of glucosamine (n = 101)
Number of subjects: 205
Study 15501201 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 104)
Number of subjects: 205
Study 10831989 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (100 microgram)
Number of subjects: 236
Study 10831989 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (25 microgram)
Number of subjects: 236
Study 9180103 — intervention group
Group type: EXPERIMENTAL
Intervention: E6010 (0.22 mg/kg body weight intravenously over 2 min)
Number of subjects: 199
Study 9180103 — intervention group
Group type: COMPARATOR
Intervention: Native t-PA (28.8 mg or 14.4 million IU, 10% over 1 to 2 min, remainder over 60 min)
Number of subjects: 199
Study 8267066 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg of oral slow‐release isradipine twice a day
Number of subjects: 42
Study 8267066 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg of methyldopa three times a day
Number of subjects: 42
Study 8267066 — intervention group
Group type: COMPARATOR
Intervention: 5 mg of oral slow‐release isradipine twice a day
Number of subjects: 42
Study 8267066 — intervention group
Group type: COMPARATOR
Intervention: Matched controls without medication
Number of subjects: 42
Study 3749828 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 1% (2 ml)
Number of subjects: 24
Study 3749828 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (Voltaren) (50 mg, 2 ml)
Number of subjects: 24
Study 30915663 — intervention group
Group type: COMPARATOR
Intervention: RT-HIIT
Number of subjects: 206
Study 30915663 — intervention group
Group type: COMPARATOR
Intervention: AT-HIIT
Number of subjects: 206
Study 28801938 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1500 mg/day
Number of subjects: 83
Study 25938296 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic telerounding (RP-7 robot)
Number of subjects: 20
Study 25938296 — intervention group
Group type: COMPARATOR
Intervention: Conventional telephone rounds
Number of subjects: 20
Study 23468980 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant iodine-125 brachytherapy
Number of subjects: 68
Study 23468980 — intervention group
Group type: COMPARATOR
Intervention: Best care (control)
Number of subjects: 68
Study 21527583 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFB1 (rs1982073)
Number of subjects: 6703
Study 21527583 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFBR1 (rs10512263)
Number of subjects: 6703
Study 21527583 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFBR2 (rs4522809)
Number of subjects: 6703
Study 21527583 — intervention group
Group type: COMPARATOR
Intervention: Endothelial-specific pathway SNPs (ALK1/SMADs 1&5)
Number of subjects: 6703
Study 18054611 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) therapy
Number of subjects: 58
Study 18054611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 16529338 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-guided education and monitoring (PGEM)
Number of subjects: 60
Study 16529338 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 14633803 — intervention group
Group type: EXPERIMENTAL
Intervention: New Dietary Education (NDE) program
Number of subjects: 173
Study 14633803 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional dietary education)
Number of subjects: 173
Study 10566918 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40
Study 10566918 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 40
Study 10566918 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 8750483 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for at least one year
Number of subjects: 0
Study 8750483 — intervention group
Group type: COMPARATOR
Intervention: Control group not receiving HRT
Number of subjects: 0
Study 2049556 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (K)
Number of subjects: 125
Study 2049556 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 125
Study 6124261 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenylhydantoin
Number of subjects: 35
Study 6124261 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrroxan
Number of subjects: 35
Study 6124261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 31856747 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant food hygiene intervention targeting caregiver behaviours (hand washing, boiling food, storing food in sealed containers, using specific utensils)
Number of subjects: 750
Study 31856747 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant food hygiene intervention
Number of subjects: 750
Study 27893032 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Cognitive Processing Therapy (CPT) - 60-minute sessions, twice weekly for 6 weeks
Number of subjects: 268
Study 27893032 — intervention group
Group type: COMPARATOR
Intervention: Group Cognitive Processing Therapy (CPT) - 90-minute sessions, twice weekly for 6 weeks
Number of subjects: 268
Study 27893032 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formats (Individual and Group CPT)
Number of subjects: 268
Study 27813396 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled anopexy (SA)
Number of subjects: 70
Study 27813396 — intervention group
Group type: COMPARATOR
Intervention: Transanal hemorrhoidal dearterialization (THD)
Number of subjects: 70
Study 27813396 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques (SA and THD)
Number of subjects: 70
Study 24850844 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular booster immunizations every 2 weeks (arm 1)
Number of subjects: 16
Study 24850844 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized schedules of immunization determined using real-time immune monitoring (arm 2)
Number of subjects: 16
Study 24850844 — intervention group
Group type: COMPARATOR
Intervention: Both arms (1 and 2)
Number of subjects: 16
Study 22253758 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Age
Number of subjects: 32
Study 22253758 — intervention group
Group type: COMPARATOR
Intervention: Tetris
Number of subjects: 32
Study 20883232 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 200
Study 17389458 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) therapy, mean dose 0.16±0.06 mg/day
Number of subjects: 34
Study 17389458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 16147225 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice course (8 consecutive sessions)
Number of subjects: 16
Study 11952543 — intervention group
Group type: EXPERIMENTAL
Intervention: Single consultation with a primary care nurse for 30 minutes
Number of subjects: 235
Study 11952543 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 235
Study 9440387 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA diet
Number of subjects: 100
Study 9440387 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 100
Study 8570366 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive attitude toward speech
Number of subjects: 40
Study 8570366 — intervention group
Group type: COMPARATOR
Intervention: Neutral attitude toward speech
Number of subjects: 40
Study 2001087 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone (300 mg three times daily in 19 patients, 300 mg twice daily in 3 patients, and 150 mg twice daily in 1 patient)
Number of subjects: 33
Study 2001087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 6340806 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops after placebo or 80 mg propranolol
Number of subjects: 19
Study 6340806 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops after 160 mg propranolol
Number of subjects: 19
Study 6340806 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops after 120 mg propranolol
Number of subjects: 19
Study 6340806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 6340806 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 19
Study 6340806 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 19
Study 6340806 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg
Number of subjects: 19
Study 30817752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for child SepAD (TAFF or CC)
Number of subjects: 107
Study 30817752 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 107
Study 30256184 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Education (PSE)
Number of subjects: 223
Study 30256184 — intervention group
Group type: COMPARATOR
Intervention: Usual services (Control)
Number of subjects: 223
Study 25547036 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) defined as an apnea-hypopnea-index (AHI) ≥15 events/h
Number of subjects: 431
Study 25547036 — intervention group
Group type: COMPARATOR
Intervention: No obstructive sleep apnea (no OSA) defined as an AHI <5
Number of subjects: 431
Study 25547036 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA)
Number of subjects: 431
Study 23834227 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + ATS (n = 29)
Number of subjects: 173
Study 23834227 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + ETS (n = 41)
Number of subjects: 173
Study 23834227 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (n = 103)
Number of subjects: 173
Study 23834227 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + ATS (n = 39) at follow-up
Number of subjects: 173
Study 23834227 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + ETS (n = 64) at follow-up
Number of subjects: 173
Study 21305227 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 66
Study 21305227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 19506295 — intervention group
Group type: EXPERIMENTAL
Intervention: Active consent procedures
Number of subjects: 14
Study 19506295 — intervention group
Group type: COMPARATOR
Intervention: Passive consent procedures
Number of subjects: 14
Study 16815260 — intervention group
Group type: EXPERIMENTAL
Intervention: Short questionnaire for dry eye syndrome (DES)
Number of subjects: 690
Study 15124838 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated, water-filled mattress (HWM)
Number of subjects: 74
Study 15124838 — intervention group
Group type: COMPARATOR
Intervention: Incubator care
Number of subjects: 74
Study 11215748 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (0.1 mg subcutaneously three times a day)
Number of subjects: 50
Study 11215748 — intervention group
Group type: COMPARATOR
Intervention: Control (conservative treatment only)
Number of subjects: 50
Study 8628802 — intervention group
Group type: EXPERIMENTAL
Intervention: Textured implants
Number of subjects: 61
Study 8628802 — intervention group
Group type: COMPARATOR
Intervention: Smooth-walled implants
Number of subjects: 61
Study 1728731 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics
Number of subjects: 2847
Study 1728731 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative antibiotics
Number of subjects: 2847
Study 1728731 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics
Number of subjects: 2847
Study 1728731 — intervention group
Group type: EXPERIMENTAL
Intervention: Early antibiotics (2 to 24 hours before incision)
Number of subjects: 2847
Study 6142643 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam 10 mg in its commercially available form
Number of subjects: 120
Study 6142643 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam 10 mg masked in opaque capsules
Number of subjects: 120
Study 6142643 — intervention group
Group type: EXPERIMENTAL
Intervention: hydroxyzine pamoate 50 mg in its commercially available form
Number of subjects: 120
Study 6142643 — intervention group
Group type: EXPERIMENTAL
Intervention: hydroxyzine pamoate 50 mg masked in opaque capsules
Number of subjects: 120
Study 6142643 — intervention group
Group type: COMPARATOR
Intervention: anxiety scores
Number of subjects: 120
Study 6142643 — intervention group
Group type: COMPARATOR
Intervention: previous drug therapy
Number of subjects: 120
Study 30782895 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated pelvic floor muscle training (PFMT)
Number of subjects: 600
Study 30782895 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 600
Study 30782895 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated PFMT
Number of subjects: 600
Study 30782895 — intervention group
Group type: COMPARATOR
Intervention: PFMT
Number of subjects: 600
Study 29338782 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 200
Study 29338782 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet group
Number of subjects: 200
Study 29338782 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 29338782 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group vs Booklet group
Number of subjects: 200
Study 26980878 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media intervention to promote HIV testing
Number of subjects: 0
Study 26980878 — intervention group
Group type: COMPARATOR
Intervention: Comparison communities (control)
Number of subjects: 0
Study 24625508 — intervention group
Group type: COMPARATOR
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 2317
Study 24625508 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine laboratory and clinical monitoring (LCM)
Number of subjects: 2317
Study 24625508 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line therapy
Number of subjects: 2317
Study 24625508 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line therapy
Number of subjects: 2317
Study 22727286 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy and gas tamponade
Number of subjects: 98
Study 22727286 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 98
Study 20847066 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent anesthesia before and continuously during EVLT (Group B)
Number of subjects: 25
Study 20847066 — intervention group
Group type: COMPARATOR
Intervention: Classical tumescent anesthesia before ablation (Group A)
Number of subjects: 25
Study 17592197 — intervention group
Group type: EXPERIMENTAL
Intervention: DDIR mode
Number of subjects: 24
Study 17592197 — intervention group
Group type: COMPARATOR
Intervention: DDDR mode
Number of subjects: 24
Study 15660075 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg po preoperatively and Dexamethasone 10 mg IV intraoperatively
Number of subjects: 29
Study 15660075 — intervention group
Group type: COMPARATOR
Intervention: Placebo po preoperatively and Placebo IV intraoperatively
Number of subjects: 29
Study 15660075 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg po preoperatively
Number of subjects: 29
Study 15660075 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo po preoperatively and Dexamethasone 10 mg IV intraoperatively
Number of subjects: 29
Study 11873024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine, 0.75% (n = 10)
Number of subjects: 20
Study 11873024 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine, 0.75% (n = 10)
Number of subjects: 20
Study 11873024 — intervention group
Group type: COMPARATOR
Intervention: Both ropivacaine and bupivacaine
Number of subjects: 20
Study 10100362 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigating fluids containing glycine, mannitol, and sorbitol infused at 0.75 ml/kg/min for 20 min
Number of subjects: 10
Study 9878638 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline and rifampin impregnated catheters
Number of subjects: 865
Study 9878638 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine and silver sulfadiazine impregnated catheters
Number of subjects: 865
Study 2238575 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIG) therapy
Number of subjects: 30
Study 2238575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 328244 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine HC1 (Symmetrel)
Number of subjects: 42
Study 328244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 31090087 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL and CO2 ablative fractional laser (AFL)
Number of subjects: 23
Study 31090087 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 AFL alone
Number of subjects: 23
Study 31090087 — intervention group
Group type: COMPARATOR
Intervention: Control (no laser treatment)
Number of subjects: 23
Study 28545482 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone
Number of subjects: 0
Study 28545482 — intervention group
Group type: EXPERIMENTAL
Intervention: single-arm trial
Number of subjects: 0
Study 28545482 — intervention group
Group type: COMPARATOR
Intervention: randomized controlled trial
Number of subjects: 0
Study 26419795 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (8 weeks)
Number of subjects: 20
Study 26419795 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 20
Study 23786821 — intervention group
Group type: EXPERIMENTAL
Intervention: Buttermilk (45 g/d)
Number of subjects: 34
Study 23786821 — intervention group
Group type: COMPARATOR
Intervention: Placebo (45 g/d)
Number of subjects: 34
Study 21801508 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (≥12 sessions of five-element acupuncture)
Number of subjects: 80
Study 21801508 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care, starting after 26 weeks)
Number of subjects: 80
Study 21801508 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 80
Study 21801508 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture and Control
Number of subjects: 80
Study 19254438 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with moderate level of transference interpretations
Number of subjects: 100
Study 19254438 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy without transference interpretations
Number of subjects: 100
Study 19254438 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with transference interpretations
Number of subjects: 100
Study 17001071 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg) administered monthly for 3 months
Number of subjects: 31